3D-liver perfusion MRI with the MS-325 blood pool agent: A noninvasive protocol to asses liver fibrosis

3D-liver perfusion MR imaging with MS-325 blood pool contrast agent to evaluate liver fibrosis

Introduction Liver fibrosis is an important cause of mortality and morbidity in patients with chronic liver diseases. Fibrosis can lead to cirrhosis from which the complications involve 15,000 deaths per year in France [1]. Recently, the studies about the mechanism of hepatic fibrogenesis have shown the reversible aspect of liver fibrosis and have allowed the emergence of more effective treatme...

3D MRA visualization and artery-vein separation using blood-pool contrast agent MS-325.

Magnetic resonance angiography (MRA) is established as an important complementary technique to conventional angiography, and contrast–enhanced MRA (CE-MRA) offers even higher contrast between the vascular lumen and surrounding structures. MS-325 is a gadolinium-based MR contrast agent designed specifically for blood-pool imaging, or MRA, and is the only gadolinium-based intravascular contrast a...

noninvasive methods to evaluate liver fibrosis in chronic hcv infection

liver fibrosis and noninvasive serum based biomarkers

0

MRI of Liver Fibrosis by Fibrin-Fibronectin Targeted Contrast Agent

D. S. Gao, M. Tan, J. S. Cheung, A. M. Chow, S. J. Fan, K. W. Chan, K. Man, Z-R. Lu, and E. X. Wu Laboratory of Biomedical Imaging and Signal Processing, The University of Hong Kong, Pokfulam, Hong Kong SAR, China, People's Republic of, Department of Electrical and Electronic Engineering, The University of Hong Kong, Pokfulam, Hong Kong SAR, China, People's Republic of, Department of Biomedical...